Rj. Blanchard et al., AN ETHOPHARMACOLOGICAL ANALYSIS OF SELECTIVE ACTIVATION OF 5-HT1A RECEPTORS - THE MOUSE 5-HT1A SYNDROME, Pharmacology, biochemistry and behavior, 57(4), 1997, pp. 897-908
The behavioral effects of 8-OH-DPAT [0.5-10 mg/kg intraperitoneally (I
P)] and (+) S-20499 (1-20 mg/kg IF), a recently synthesized 5-HT1A rec
eptor full agonist, were examined over a 2-h period in mice in a neutr
al cage and, during the peak period of effect, in a runway. 8-OH-DPAT
(1 and 10 mg/kg) and (+) S-20499 (10 and 20 mg/kg) blocked vertical ac
tivity (i.e., rearing and hanging on the wire mesh) during the period
postinjection when levels of activity of the control mice were high. I
n this initial period (0-30 min), mice treated with 8-OH-DPAT, but not
those treated with (+) S-20499, displayed flat back rather than curve
back locomotion (0.5-10 mg/kg). However, after about 50 min, marked h
yperactivity emerged for 8-OH-DPAT at 0.5 and 1 mg/kg and for (+) S-20
499 at all doses, including increases in rearing, hanging, grooming. a
nd, for (+) S-20499, curve back locomotion. Both 8-OH-DPAT (10 mg/kg)
and (+) S-20499 (>20 mg/kg) significantly enhanced eating responses. B
oth drugs rapidly induced straub tail responses at all doses, and this
effect remained significant until the end of the experiment at the hi
ghest doses. Subjects treated with 0.5 mg/kg of 8-OH-DPAT and 10 mg/kg
of (+) S-20499 displayed in the initial time period ''ballistic-type'
' rapid forelimb movements targeted toward the side of the head. Durin
g peak drug effect periods, higher doses of both drugs produced signif
icant increases in movement with a change of direction, including rota
tion around the hindlimbs, suggesting, as do the ballistic-type moveme
nts, particular involvement of the forelimbs. These findings provide e
vidence consonant with the view that selective activation of 5-HT1A re
ceptors in mice produces distinct behavioral changes in part associate
d with the 5-HT syndrome. Moreover, these changes differ, in the speci
fic movements induced and in the drug parameters and time course of ch
anges, from those reported in the laboratory rat. (C) 1997 Elsevier Sc
ience Inc.